A Study to See if New Device Technology Can Tell the Difference Between Non-cancer and Cancerous Melanoma

Overview

About this study

The purpose of this study is to use new technology called Optical Transfer Diagnosis (OTD) to find if skin lesions are melanomas or non cancer. The research study team wants to see if the Balter Medical OTD technology will identify these lesions the same or better than a dermatologist.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

A total of 300 patients in sets of 50 patients
Individuals capable of giving informed consent
Over the age of 17
Biopsy or excision of suspicious pigmented lesions is planned
Women who are pregnant and/or nursing may take part in this study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator David Swanson, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

David Swanson, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials